These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 36585927)

  • 1. The tumor microenvironment in gastrointestinal adenocarcinomas revealed a prognostic and immunotherapeutic biomarker.
    Zhang Y; Li L; Chu F; Zhang L; Zhang L; Wu H; Li K
    Aging (Albany NY); 2022 Dec; 14(24):10171-10216. PubMed ID: 36585927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of Tumor Microenvironment in Lung Adenocarcinoma Identifies Immune Signatures to Predict Clinical Outcomes and Therapeutic Responses.
    Chen D; Wang Y; Zhang X; Ding Q; Wang X; Xue Y; Wang W; Mao Y; Chen C; Chen Y
    Front Oncol; 2021; 11():581030. PubMed ID: 33747907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor microenvironment characterization in colorectal cancer to identify prognostic and immunotherapy genes signature.
    Guo XW; Lei RE; Zhou QN; Zhang G; Hu BL; Liang YX
    BMC Cancer; 2023 Aug; 23(1):773. PubMed ID: 37596528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor Microenvironment Characterization in Gastric Cancer Identifies Prognostic and Immunotherapeutically Relevant Gene Signatures.
    Zeng D; Li M; Zhou R; Zhang J; Sun H; Shi M; Bin J; Liao Y; Rao J; Liao W
    Cancer Immunol Res; 2019 May; 7(5):737-750. PubMed ID: 30842092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of multiple key molecules in lung adenocarcinoma identifies prognostic and immunotherapeutic relevant gene signatures.
    Wu Q; Wang L; Wei H; Li B; Yang J; Wang Z; Xu J; Zhou YL; Zhang B
    Int Immunopharmacol; 2020 Jun; 83():106477. PubMed ID: 32278127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor Microenvironment Characterization in Glioblastoma Identifies Prognostic and Immunotherapeutically Relevant Gene Signatures.
    Zhang J; Xiao X; Zhang X; Hua W
    J Mol Neurosci; 2020 May; 70(5):738-750. PubMed ID: 32006162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving ovarian cancer treatment decision using a novel risk predictive tool.
    Xu Z; Song J; Cao L; Rong Z; Zhang W; He J; Li K; Hou Y
    Aging (Albany NY); 2022 Apr; 14(8):3464-3483. PubMed ID: 35439731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor Microenvironment Profiling Identifies Prognostic Signatures and Suggests Immunotherapeutic Benefits in Neuroblastoma.
    Feng C; Li T; Xiao J; Wang J; Meng X; Niu H; Jiang B; Huang L; Deng X; Yan X; Wu D; Fang Y; Lin Y; Chen F; Wu X; Zhao X; Feng J
    Front Cell Dev Biol; 2022; 10():814836. PubMed ID: 35493068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive Genomic Characterization of Tumor Microenvironment and Relevant Signature in Clear Cell Renal Cell Carcinoma.
    Zhang C; Qi F; Zheng Y; Xia X; Li X; Wang X
    Front Oncol; 2022; 12():749119. PubMed ID: 35651807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Significance of Tumor Microenvironment Score for Breast Cancer Patients.
    Tian Y; Wang J; Wen Q; Gao A; Huang A; Li R; Zhang Y; Su G; Sun Y
    Biomed Res Int; 2022; 2022():5673810. PubMed ID: 35528180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the Immune Cell Infiltration Landscape Uncovers Prognostic and Immunogenic Characteristics in Lung Adenocarcinoma.
    Wang X; Xu Z; Liu Z; Lin W; Cao Z; Feng X; Gao Y; He J
    Front Genet; 2022; 13():902577. PubMed ID: 35677561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune Infiltrating Cells-Derived Risk Signature Based on Large-scale Analysis Defines Immune Landscape and Predicts Immunotherapy Responses in Glioma Tumor Microenvironment.
    Zhang N; Zhang H; Wang Z; Dai Z; Zhang X; Cheng Q; Liu Z
    Front Immunol; 2021; 12():691811. PubMed ID: 34489938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined signature of N7-methylguanosine regulators with their related genes and the tumor microenvironment: a prognostic and therapeutic biomarker for breast cancer.
    Li T; Chen Z; Wang Z; Lu J; Chen D
    Front Immunol; 2023; 14():1260195. PubMed ID: 37868988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the Tumor Microenvironment in Osteosarcoma Identifies Prognostic- and Immunotherapy-Relevant Gene Signatures.
    Tan J; Feng X; Wu H; Yang B; Shi M; Xie C; Su Z; Li L; Luo M; Zuo Z; Zhu S; Yang J; Lin L
    J Immunol Res; 2022; 2022():6568278. PubMed ID: 36065454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying prognostic signatures in the microenvironment of prostate cancer.
    Lu G; Cai W; Wang X; Huang B; Zhao Y; Shao Y; Wang D
    Transl Androl Urol; 2021 Nov; 10(11):4206-4218. PubMed ID: 34984186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a personalized classifier to predict the prognosis and response to immunotherapy in glioma based on glycolysis and the tumor microenvironment.
    Fan P; Xia J; Zhou M; Zhuo C; He H
    PeerJ; 2023; 11():e16066. PubMed ID: 37744243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor Microenvironment Analysis Identified Subtypes Associated With the Prognosis and the Tumor Response to Immunotherapy in Bladder Cancer.
    Zhang H; Song J; Dong J; Liu Z; Lin L; Wang B; Ma Q; Ma L
    Front Genet; 2021; 12():551605. PubMed ID: 33732281
    [No Abstract]   [Full Text] [Related]  

  • 18. A cellular senescence-related classifier based on a tumorigenesis- and immune infiltration-guided strategy can predict prognosis, immunotherapy response, and candidate drugs in hepatocellular carcinoma.
    Luo Y; Liu H; Fu H; Ding GS; Teng F
    Front Immunol; 2022; 13():974377. PubMed ID: 36458010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The significance of m6A RNA methylation modification in prognosis and tumor microenvironment immune infiltration of cervical cancer.
    Guo Y; Bai Y; Wang L; Xu Z; Wang X; Wang W
    Medicine (Baltimore); 2022 Jul; 101(26):e29818. PubMed ID: 35777046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leveraging Tumor Microenvironment Infiltration in Pancreatic Cancer to Identify Gene Signatures Related to Prognosis and Immunotherapy Response.
    Yang J; Zeng L; Chen R; Huang L; Wu Z; Yu M; Zhou Y; Chen R
    Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.